Comparative Proteomic Analysis Uncovers Potential Biomarkers Involved in the Anticancer Effect of Scutellarein in Human Gastric Cancer Cells
Total Page:16
File Type:pdf, Size:1020Kb
ONCOLOGY REPORTS 44: 939-958, 2020 Comparative proteomic analysis uncovers potential biomarkers involved in the anticancer effect of Scutellarein in human gastric cancer cells VENU VENKATARAME GOWDA SARALAMMA1,2, PREETHI VETRIVEL1, HO JEONG LEE3, SEONG MIN KIM1, SANG EUN HA1, RAJESWARI MURUGESAN4, EUN HEE KIM5, JEONG DOO HEO3 and GON SUP KIM1 1Research Institute of Life Science and College of Veterinary Medicine, Gyeongsang National University, Jinju, Gyeongnam 52828; 2College of Pharmacy, Yonsei University, Incheon 21983; 3Gyeongnam Department of Environment Toxicology and Chemistry, Biological Resources Research Group, Korea Institute of Toxicology, Jinju, Gyeongnam 52834, Republic of Korea; 4Department of Biochemistry, Biotechnology and Bioinformatics, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore, Tamil Nadu 641043, India; 5Department of Nursing Science, International University of Korea, Jinju, Gyeongnam 52833, Republic of Korea Received December 19, 2019; Accepted May 28, 2020 DOI: 10.3892/or.2020.7677 Abstract. Scutellarein (SCU), a flavone that belongs to the studies also confirmed the binding affinity of SCU towards flavonoid family and abundantly present in Scutellaria these critical proteins. Phosphatidylinositol 4,5‑bisphosphate baicalensis a flowering plant in the family Lamiaceae, has been 3‑kinase catalytic subunit β isoform (PIK3CB) protein expres- reported to exhibit anticancer effects in several cancer cell lines sion was accompanied by a distinct group of cellular functions, including gastric cancer (GC). Although our previous study including cell growth, and proliferation. Cancerous inhibitor documented the mechanisms of Scutellarein‑induced cyto- of protein phosphatase 2A (CIP2A), is one of the oncogenic toxic effects, the literature shows that the proteomic changes molecules that have been shown to promote tumor growth that are associated with the cellular response to SCU have been and resistance to apoptosis and senescence‑inducing thera- poorly understood. To avoid adverse side‑effects and signifi- pies. In the present study, both PIK3CB and CIP2A proteins cant toxicity of chemotherapy in patients who react poorly, were downregulated in SCU‑treated cells, which boosts our biomarkers anticipating therapeutic responses are imperative. previous results of SCU to induce apoptosis and inhibits GC In the present study, we utilized a comparative proteomic cell growth by regulating these critical proteins. The compara- analysis to identify proteins associated with Scutellarein tive proteomic analysis has yielded candidate biomarkers of (SCU)‑induced cell death in GC cells (AGS and SNU484), by response to SCU treatment in GC cell models and further integrating two‑dimensional gel electrophoresis (2‑DE), mass validation of these biomarkers will help the future clinical spectrometry (MS), and bioinformatics to analyze the proteins. development of SCU as a novel therapeutic drug. Proteomic analysis between SCU‑treated and DMSO (control) samples successfully identified 41 (AGS) and 31 (SNU484) Introduction proteins by MALDI‑TOF/MS analysis and protein database search. Comparative proteomics analysis between AGS and Gastric cancer was the fifth most prevalent malignancy in 2018 SNU484 cells treated with SCU revealed a total of 7 protein globally with an estimated 1 million new cases. Korea has been identities commonly expressed and western blot analysis listed first among the global GC cases, with stomach cancer validated a subset of identified critical proteins, which were incidence rates in men of approximately 58 per 100,000 and in consistent with those of the 2‑DE outcome. Molecular docking women of 24 per every 100,000, which is an unfortunate reality for many Koreans (1). Epigenetic alterations, aberrant molec- ular signaling pathways, and multiple genetic mutations are engaged in the development of GC (2). Substantial advances in Correspondence to: Professor Gon Sup Kim, Research Institute diagnostic techniques, chemotherapy and surgical approaches, of Life Science and College of Veterinary Medicine, Gyeongsang treatment by multidisciplinary teams and the advancement National University, 501 Jinju‑daero, Jinju, Gyeongnam 52828, of novel therapeutic agents have shown minor improvement Republic of Korea in survival rate in recent times (3). If we can identify the E‑mail: [email protected] biomarkers of drug treatment responses and their efficacy, the unnecessary burden of adverse effects and noticeable toxicity Key words: biomarkers, gastric cancer, scutellarein, from chemotherapy on GC patients unlikely to respond can be two‑dimensional gel electrophoresis, CIP2A, PIK3CB averted (4). It is imperative to identify the specific biomarkers and unique molecular patterns of the tumor to develop treat- ments that target the distinct tumor behavior. In the standard 940 SARALAMMA et al: PROTEIN PROFILING OF GC CELLS TREATED WITH SCUTELLAREIN treatment of GC, a significant number of novel anticancer Materials and methods agents targeting dysfunctional molecular signaling pathways has been reported already, whereas others remain elusive (5,6). Cell lines, reagents and antibodies. Human GC cell lines, The global proteomic approach is one of the computational AGS and SNU484, were procured from the Korea Cell technologies that have been improved in recent times over Line Bank (Seoul, Korea). Antibiotics (penicillin/strepto- many other complementary techniques that briskly change our mycin), fetal bovine serum (FBS) and RPMI‑1640 growth approach to cancer research (7). This empowers scientists to medium were purchased from Gibco, Thermo Fisher screen substantial numbers of proteins within clinical discrete Scientific, Inc. Compound Scutellarein was procured samples, as well as different cell lines treated with specific from Chengdu Biopurify Phytochemicals Ltd. (product drugs that help to analyze and confirm drug targets, find new no. 611130). Chemicals and materials utilized for electro- disease biomarkers, design more adequate drugs, and estimate phoresis were procured from Bio‑Rad Laboratories, Inc. drug efficacy (8). The conventional proteomics approach was 3‑(4,5‑Dimethylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bromide achieved by implementing a combination of 2‑DE coupled with (MTT) was purchased from Duchefa Biochemie. Antibodies differential image analysis and protein identification using mass for CIP2A (#148053) and PI3KCB (#3011S) were purchased spectrometry (MALDI‑TOF; matrix‑assisted laser desorption/ from Cell Signaling Technology, Inc. OFD1 (#ab222837), ionization‑time of flight) and bioinformatics to predominantly VCL (#ab129002), and HIP1R (#ab226197) antibodies were identify and characterize proteins in the tissues and cells purchased from Abcam. The β‑actin (#MABT825) antibody from both in‑vitro and in‑vivo models (8,9). Protein network, was purchased from Millipore. functional interpretation, and pathway analysis tools can help to address the difficulties in the illustration of the obtained Treatment of SCU and determination of cell viability. proteomics data. To identify the activated pathway element Mycoplasma‑free AGS and SNU484 cells were cultured in of functional proteomic data, the analysis of proteomic data RPMI‑1640 medium containing 10% FBS (heat activated) and at the pathway level has become universally popular (10). The 1% antibiotics (penicillin/streptomycin) in an incubator with comparative proteomic analysis could persuade the molecular 5% CO2 at 37˚C in a humidified condition. To confirm myco- characterization of cellular events correlated with cancer devel- plasma contamination, we used the e‑Myco™ Mycoplasma opmental, signaling, and progression phases that leads to the PCR Detection kit (iNtRON Biotechnology). Cell viability discovery of cancer‑specific protein markers, which provides assay was performed using MTT assay. The cells were at a the basis for understanding cancer progression, carcinogenesis density of 5x105 cells per well in 24‑well plates and grown and targets of protein molecules for anticancer agents (11). overnight. Subsequently treat the cells were treated with the Herbal products and their components have been identi- indicated concentrations of SCU (0, 25, 50, 75, and 100 µM) fied as exhibiting anticancer effects by targeting dysregulated for 24 h at 37˚C. An amount 50 µl of MTT solution (0.5 mg/ml) genes that contribute to carcinogenesis in several cancer cell was added to each well after 24 h, and incubation was carried lines by multiple cell signaling pathways (12,13). Flavonoids out at 37˚C for 3 h in a dark condition. DMSO (300 µl) was are natural polyphenolic compounds that are abundantly added to each well to solubilize the formazan contained in present in plant parts, especially in leaves and fruits, and the cells, and the absorbance was measured at 540 nm using previous studies have demonstrated several anticancer effects a microplate reader (BioTek Instruments). Cell viability was by regulating multiple cellular mechanisms such as the expressed as a percentage of the control and experiments were PI3K/AKT/mTOR signaling pathway (13,14). Fig. 1A shows conducted in triplicates for each assay condition. Scutellarein (SCU), a flavone, which belongs to the family of flavonoids, that are abundantly present in perpetual herbs, Protein sample preparation for 2‑DE analysis. AGS and such as Scutellaria barbata and Scutellaria baicalensis. SNU484 cells were treated or untreated (control) with SCU Studies have demonstrated that SCU